BMS-986523
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986523, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies [Phase 1, Phase 2]